Results 211 to 220 of about 206,382 (334)

Genotype-Guided Dosing of Vitamin K Antagonists [PDF]

New England Journal of Medicine, 2014
Maitland-van der Zee, A.H., de Boer, Anthonius, Manolopoulos, V.G.   +2 more
openaire   +10 more sources

Adropin modulates pancreatic cell proliferation and glutathione levels in an animal model of type 1 diabetes mellitus

Animal Models and Experimental Medicine, EarlyView.
Adropin is related to the energy homeostasis‐associated gene. It significantly increased glutathione reductase enzyme levels in the pancreas of experimental diabetic rats. Adropin may reduce the severity of diabetes and its complications. Cell proliferation in the exocrine is reduced after the administration of adropin.
Ifrah I. Ali, Crystal D'Souza, Abderrahim Nemmar, Shreesh Ojha, Ernest A. Adeghate   +4 more
wiley   +1 more source

Optimization of vitamin K antagonist treatment: Near patient monitoring versus standard of care a parallel group clinical trial in older patients with atrial fibrillation. [PDF]

Eur J Clin Pharmacol
van Elp M, Beinema M, Brouwers JRBJ, van 't Riet E, van de Leur S, Schreiber I, Jansman FGA.   +6 more
europepmc   +1 more source

Effect of Some Risk Factors on Over-Anticoagulation Disorders and Bleeding in Patients Receiving Anticoagulant Therapy with Overdosage of Vitamin K Antagonist. [PDF]

Vasc Health Risk Manag, 2023
Dung Chu S, Thi Tran M.
europepmc   +1 more source

Management of Patients on Non–Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association

Circulation, 2017
A. Raval, J. Cigarroa, M. Chung, Larry J Diaz-Sandoval, D. Diercks, J. Piccini, Hee Soo Jung, J. Washam, B. Welch, A. Zazulia, S. Collins   +10 more
semanticscholar   +1 more source

Temporal glomerular gene expression dynamics during disease progression in a mouse model of hypertension‐accelerated diabetic kidney disease

Animal Models and Experimental Medicine, EarlyView.
The current study characterized temporal changes in glomerular gene expression, pathology, and biomarkers in a mouse model of hypertension‐accelerated diabetic kidney disease (DKD). Progressive albuminuria and glomerulosclerosis were paralleled by dynamic transcriptomic changes associated withmetabolic dysfunction, extracellular matrix remodeling, and ...
Adam B. Marstrand‐Jørgensen, Frederikke Emilie Sembach, Maria Ougaard, Ditte Hansen, Mette Viberg Østergaard, Henrik H. Hansen, Louise S. Dalbøge, Ole Jørgen Kaasbøll, Michael Christensen   +8 more
wiley   +1 more source

Correction to "Quality of vitamin K antagonist treatment during the last year of life". [PDF]

Hemasphere
europepmc   +1 more source

Early use of non-vitamin K antagonist oral anticoagulants after cardiac surgery compared with warfarin for postoperative atrial fibrillation. [PDF]

ANZ J Surg
Chang S, Lombardo A, Smith I, Lawler S, He C, Stroebel A.   +5 more
europepmc   +1 more source

Decoding the Pathophysiology of Autoimmune Diseases—Mechanism, Triggers, and Nanotherapeutics: A Review

Advanced NanoBiomed Research, EarlyView.
This review highlights how autoimmune diseases arise from intertwined immunological, genetic, and environmental factors, emphasizing gut microbiota dysbiosis as a pivotal driver. It outlines emerging nanotechnology‐based strategies—such as liposomes, hydrogels, and polymeric nanoparticles—that enhance targeted drug delivery, minimize systemic toxicity,
Md. Meraj Ansari, Yunhui Min, Eun‐Ju Ko, Doyoung Kwon, Rehan Khan, Young‐Ok Son   +5 more
wiley   +1 more source

Clinical Outcome and Costs Based on the Degree of Vitamin K Antagonist Control for Non-Valvular Atrial Fibrillation. [PDF]

J Clin Med
Dalmau Llorca MR, Hernández Rojas Z, Castro Blanco E, Carrasco-Querol N, Gonçalves AQ, Espuny Cid A, Fernández Sáez J, García-Goñi M, Pérez-Villacastín J, Aguilar Martín C.   +9 more
europepmc   +1 more source